Octagon Research, a provider of software and services to the life sciences industry, today announced the release of a global document authoring template suite.
Octagon Research Solutions, Inc. Releases startingpoint® 3.2Global Submission Document Authoring Template Suite Includes Over 230 Templates
(WAYNE, PA, November 7, 2008) - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leading provider of breakthrough software and services to the life sciences industry, today announced the release of StartingPoint® 3.2. With over 120 clients, Octagon’s StartingPoint global document authoring template suite has proven to be a preferred solution for organizations seeking to standardize their authoring processes in support of electronic submissions.
Some of the new enhancements to StartingPoint 3.2 include:
John Lawrie, vice president, Process Solutions at Octagon Research Solutions, Inc. noted, “Evolving global submission standards are adding complexity to the already challenging submission authoring process. Since StartingPoint was first released in 2003, we have worked closely with our internal experts and clients to continue to enhance our suite of templates to support this changing environment. This new release will provide greater flexibility for authors and improve document quality.”
“Octagon’s Process and Regulatory Consultants have been dedicated to the development of this latest version of StartingPoint and their practical expertise is infused into every template,” commented John Rogers, director, Process Solutions. “Our entire portfolio of templates demonstrates the unique combination of domain expertise integrated with enabling technology that is so critical to submission document authoring and that is always associated with Octagon’s solutions.”
To see a demonstration of StartingPoint 3.2 or to learn more about Octagon’s integrated product and service offerings, please contact Octagon Research Solutions, Inc. at (610)-535-6500 or www.octagonresearch.com.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. Octagon’s EDC Operations are located in Mountain View, CA. For more information please visit www.octagonresearch.com.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity, Type 2 Diabetes
June 24th 2025In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained weight loss of up to 20% in adults with obesity, with or without type 2 diabetes, alongside notable improvements in glycemic control, supporting its advancement to Phase III studies as a potential once-monthly treatment option.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.